UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Evaluation of Molecular Properties versus In Vivo Performance of Aflibercept, Brolucizumab, and Ranibizumab in a Retinal Vascular Hyperpermeability Model

Translational vision science & technology, 2022-10, Vol.11 (10), p.36-36

2022

Volltextzugriff (PDF)

Immunomodulatory Effect of the Topical Ophthalmic Janus Kinase Inhibitor Tofacitinib (CP-690,550) in Patients with Dry Eye Disease

Ophthalmology (Rochester, Minn.), 2012-07, Vol.119 (7), p.e43-e50

2012

Volltextzugriff (PDF)

VEGFR1 signaling in retinal angiogenesis and microinflammation

Progress in retinal and eye research, 2021-09, Vol.84, p.100954-100954, Article 100954

2021

Volltextzugriff (PDF)

ANO2 Genetic Variants and Anti-VEGF Treatment Response in Neovascular AMD: A Pharmacogenetic Substudy of VIEW 1 and VIEW 2

Investigative ophthalmology & visual science, 2024-07, Vol.65 (8), p.17

2024

Volltextzugriff (PDF)

Retina expression and cross-species validation of gene silencing by PF-655, a small interfering RNA against RTP801 for the treatment of ocular disease

Journal of ocular pharmacology and therapeutics, 2012-06, Vol.28 (3), p.222-230

2012

Volltextzugriff (PDF)

Impact of Baseline Retinal Nonperfusion and Macular Retinal Capillary Nonperfusion on Outcomes in the COPERNICUS and GALILEO Studies

Ophthalmology retina, 2019-07, Vol.3 (7), p.553-560

2019

Volltextzugriff (PDF)

Aflibercept Suppression of Angiopoietin-2 in a Rabbit Retinal Vascular Hyperpermeability Model

Translational vision science & technology, 2023-05, Vol.12 (5), p.17-17

2023

Volltextzugriff (PDF)

Drug and gene delivery to the back of the eye: from bench to bedside

Investigative ophthalmology & visual science, 2014-04, Vol.55 (4), p.2714-2730

2014

Volltextzugriff (PDF)

Aflibercept Suppression of Angiopoietin-2 in a Rabbit Retinal Vascular Hyperpermeability Model

Translational vision science & technology, 2023-10, Vol.12 (10), p.5-5

2023

Volltextzugriff (PDF)

Ophthalmic drug delivery systems for the treatment of retinal diseases: basic research to clinical applications

Investigative ophthalmology & visual science, 2010-11, Vol.51 (11), p.5403-5420

2010

Volltextzugriff (PDF)

Evaluations of tear protein markers in dry eye disease: repeatability of measurement and correlation with disease

Investigative ophthalmology & visual science, 2012-07, Vol.53 (8), p.4556-4564

2012

Volltextzugriff (PDF)

Durability of VEGF Suppression With Intravitreal Aflibercept and Brolucizumab: Using Pharmacokinetic Modeling to Understand Clinical Outcomes

Translational vision science & technology, 2021-04, Vol.10 (4), p.9-9

2021

Volltextzugriff (PDF)

Plasma levels of amyloid beta and other proinflammatory mediators in patients with age-related macular degeneration

Graefe's archive for clinical and experimental ophthalmology, 2015-08, Vol.253 (8), p.1347-1354

2015

Volltextzugriff (PDF)

Integrated results from the COPERNICUS and GALILEO studies

Clinical ophthalmology (Auckland, N.Z.), 2017-01, Vol.11, p.1533-1540

2017

Volltextzugriff (PDF)

RTP801 gene expression is differentially upregulated in retinopathy and is silenced by PF-04523655, a 19-Mer siRNA directed against RTP801

Investigative ophthalmology & visual science, 2014-03, Vol.55 (3), p.1232-1240

2014

Volltextzugriff (PDF)

Measuring cone density in a Japanese macaque (Macaca fuscata) model of age-related macular degeneration with commercially available adaptive optics

Advances in experimental medicine and biology, 2014, Vol.801, p.309

2014

Volltextzugriff (PDF)

The localization of PGE2 receptor subtypes in rat retinal cultures and the neuroprotective effect of the EP2 agonist butaprost

Neurochemistry international, 2009-09, Vol.55 (4), p.199-207

2009

Volltextzugriff (PDF)

Expression of Prostaglandin PGE2 Receptors under Conditions of Aging and Stress and the Protective Effect of the EP2 Agonist Butaprost on Retinal Ischemia

Investigative ophthalmology & visual science, 2009-07, Vol.50 (7), p.3238-3248

2009

Volltextzugriff (PDF)

Ocular pharmacokinetics of fluocinolone acetonide after retisert intravitreal implantation in rabbits over a 1-year period

Journal of ocular pharmacology and therapeutics, 2004-06, Vol.20 (3), p.269-275

2004

Volltextzugriff (PDF)

Microdialysis assessment of drug delivery systems for vitreoretinal targets

Advanced drug delivery reviews, 2005-12, Vol.57 (14), p.2080-2091

2005

Volltextzugriff (PDF)

Microdialysis and drug delivery to the eye

Advanced drug delivery reviews, 2000-12, Vol.45 (2), p.229-241

2000

Volltextzugriff (PDF)

Microdialysis evaluation of the ocular pharmacokinetics of propranolol in the conscious rabbit

Pharmaceutical research, 1999-05, Vol.16 (5), p.736-742

1999

Volltextzugriff (PDF)

The localization of PGE sub(2) receptor subtypes in rat retinal cultures and the neuroprotective effect of the EP2 agonist butaprost

Neurochemistry international, 2009-09, Vol.55 (4), p.199-207

2009

Volltextzugriff (PDF)

The localization of PGE 2 receptor subtypes in rat retinal cultures and the neuroprotective effect of the EP2 agonist butaprost

Neurochemistry international, 2009, Vol.55 (4), p.199-207

2009

Volltextzugriff (PDF)

Microdialysis assessment of drug delivery systems for vitreoretinal targets: Drug delivery strategies to treat age-related macular degeneration

Advanced drug delivery reviews, 2005, Vol.57 (14), p.2080-2091

2005

Volltextzugriff (PDF)

1 – 25 von 33

Suche als RSS-Feed

Aktive Filter

KollektionNexis Uni (LexisNexis)

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(33)
Mit Volltextzugriff
(30)

Publikationsform

Artikel
(33)

Sprache

Englisch
(33)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Evaluation of Molecular Properties versus In Vivo Performance of Aflibercept, Brolucizumab, and Ranibizumab in a Retinal Vascular Hyperpermeability Model

Immunomodulatory Effect of the Topical Ophthalmic Janus Kinase Inhibitor Tofacitinib (CP-690,550) in Patients with Dry Eye Disease

VEGFR1 signaling in retinal angiogenesis and microinflammation

ANO2 Genetic Variants and Anti-VEGF Treatment Response in Neovascular AMD: A Pharmacogenetic Substudy of VIEW 1 and VIEW 2

Retina expression and cross-species validation of gene silencing by PF-655, a small interfering RNA against RTP801 for the treatment of ocular disease

Impact of Baseline Retinal Nonperfusion and Macular Retinal Capillary Nonperfusion on Outcomes in the COPERNICUS and GALILEO Studies

Aflibercept Suppression of Angiopoietin-2 in a Rabbit Retinal Vascular Hyperpermeability Model

Drug and gene delivery to the back of the eye: from bench to bedside

Aflibercept Suppression of Angiopoietin-2 in a Rabbit Retinal Vascular Hyperpermeability Model

Ophthalmic drug delivery systems for the treatment of retinal diseases: basic research to clinical applications

Evaluations of tear protein markers in dry eye disease: repeatability of measurement and correlation with disease

Durability of VEGF Suppression With Intravitreal Aflibercept and Brolucizumab: Using Pharmacokinetic Modeling to Understand Clinical Outcomes

Plasma levels of amyloid beta and other proinflammatory mediators in patients with age-related macular degeneration

Integrated results from the COPERNICUS and GALILEO studies

RTP801 gene expression is differentially upregulated in retinopathy and is silenced by PF-04523655, a 19-Mer siRNA directed against RTP801

Measuring cone density in a Japanese macaque (Macaca fuscata) model of age-related macular degeneration with commercially available adaptive optics

The localization of PGE2 receptor subtypes in rat retinal cultures and the neuroprotective effect of the EP2 agonist butaprost

Expression of Prostaglandin PGE2 Receptors under Conditions of Aging and Stress and the Protective Effect of the EP2 Agonist Butaprost on Retinal Ischemia

Ocular pharmacokinetics of fluocinolone acetonide after retisert intravitreal implantation in rabbits over a 1-year period

Microdialysis assessment of drug delivery systems for vitreoretinal targets

Microdialysis and drug delivery to the eye

Microdialysis evaluation of the ocular pharmacokinetics of propranolol in the conscious rabbit

The localization of PGE sub(2) receptor subtypes in rat retinal cultures and the neuroprotective effect of the EP2 agonist butaprost

The localization of PGE 2 receptor subtypes in rat retinal cultures and the neuroprotective effect of the EP2 agonist butaprost

Microdialysis assessment of drug delivery systems for vitreoretinal targets: Drug delivery strategies to treat age-related macular degeneration

Aktive Filter

Suchergebnisse filtern